<DOC>
	<DOCNO>NCT00774475</DOCNO>
	<brief_summary>The purpose study evaluate efficacy ( reduction major ischemic event 6 12 month follow-up ) tailor clopidogrel therapy patient UA/NSTEMI undergo PCI stent implantation wiht document residual platelet reactivity assess point care system ( VerifyNow P2Y12 ) .</brief_summary>
	<brief_title>Dual Antiplatelet Therapy Tailored Extent Platelet Inhibition</brief_title>
	<detailed_description>Several study document presence high variability individual response antiplatelet therapy term extent platelet function inhibition . This laboratory find so-called aspirin clopidogrel resistance prefer define residual platelet reactivity ( RPR ) antiplatelet therapy . A grow body evidence demonstrate clinical relevance laboratory parameter , i.e . patient RPR high risk subsequent adverse cardiovascular event . In particular , demonstrate RPR measure light transmittance aggregometry induce ADP point care assay VerifyNow P2Y12 identify patient , coronary revascularization stent implantation , high risk potentially catastrophic event stent thrombosis . No randomized trial available literature efficacy safety antiplatelet therapy tailor extent platelet function inhibition .</detailed_description>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Unstable NSTEMI Previous bleed event require blood transfusion PT INR &gt; 1.5 Platelet count ≤ 100000/ mm3 Hb &lt; 10 g/dl Previous TIA/stroke ( ischemic hemorrhagic unknown ) Body weight &lt; 60 Kg Creatinine level ≥ 4 mg/dl Cerebral neoplasia Recent major trauma/surgery/head injury ( within 3 previous week ) Gastrointestinal hemorrhage last month Aortic dissection Known haemorrhagic diathesis Oral anticoagulant therapy Pregnancy 1 week delivery Uncontrolled hypertension ( systolic &gt; 180 mmHg diastolic &gt; 110 mmHg ) Severe liver disease Infective endocarditis Major psychiatric disorder Alcool drug abuse Active peptic ulcer Noncompressible arterial puncture within 14 day Prolonged cardiopulmonary resuscitation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Clopidogrel therapy</keyword>
	<keyword>platelet function inhibition</keyword>
</DOC>